Login to Your Account

Promedior's $21.5M Series D Broadens Fibrosis Pipeline

By Trista Morrison
Staff Writer

Thursday, March 8, 2012
With deal flow indicating there's plenty of appetite for fibrosis drugs, Promedior Inc. pulled in $21.5 million in the first closing of a Series D financing aimed at advancing and expanding its fibrosis pipeline.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription